Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127687441 | 12768744 | 1 | I | 20041105 | 20160915 | 20160921 | 20160921 | EXP | AU-UCBSA-2016035524 | UCB | 52.25 | YR | M | Y | 0.00000 | 20160921 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127687441 | 12768744 | 1 | PS | KEPPRA | LEVETIRACETAM | 1 | Oral | 500 MG, 2X/DAY (BID), 1 GM DAILY DOSE | 5000 | MG | Y | U | 21035 | 500 | MG | FILM-COATED TABLET | BID | ||
| 127687441 | 12768744 | 2 | C | EPILIM | VALPROATE SODIUM | 1 | Oral | 1 GM DAILY | U | 0 | |||||||||
| 127687441 | 12768744 | 3 | C | LAMICTAL | LAMOTRIGINE | 1 | Oral | 400 MG DAILY | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127687441 | 12768744 | 1 | Epilepsy |
| 127687441 | 12768744 | 2 | Epilepsy |
| 127687441 | 12768744 | 3 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127687441 | 12768744 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127687441 | 12768744 | Confusional state | |
| 127687441 | 12768744 | Encephalitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127687441 | 12768744 | 1 | 20041101 | 20041106 | 0 |